14.04.2014 Views

The European e-Business Report The European e ... - empirica

The European e-Business Report The European e ... - empirica

The European e-Business Report The European e ... - empirica

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>The</strong> <strong>European</strong> E-<strong>Business</strong> <strong>Report</strong> 2005<br />

2.4 <strong>The</strong> Pharmaceutical Industry<br />

<strong>The</strong> e-<strong>Business</strong> W@tch sector<br />

study on the Pharmaceutical<br />

Industry was contributed by<br />

Berlecon Research GmbH (contact:<br />

info@berlecon.de).<br />

<strong>The</strong> full reports (parts 1 and 2) can<br />

be downloaded from the website<br />

(www.ebusiness-watch.org) at the<br />

'resources' section.<br />

<strong>The</strong> pharmaceutical industry is well suited to the use of ICT and e-business applications. This is true<br />

for both internal processes and for the support of B2B relationships. As a result, the industry is an<br />

intensive user of e-business. ICT and internet-based solutions also play an increasingly important role<br />

in supporting marketing and sales processes. CRM (customer relation management) systems and<br />

mobile solutions have a high potential for facilitating the management and work of the pharmaceutical<br />

sales force. Combating counterfeiting activities could be a driver for the deployment of RFID/Auto-ID<br />

solutions in this sector in the future.<br />

2.4.1 Sector definition and background<br />

Sector definition<br />

Activities subsumed under NACE 62 24.4 constitute the core of the pharmaceutical industry. <strong>The</strong><br />

reports, however, also cover the activities of the cosmetics industry (NACE 24.51) and the<br />

manufacture of soaps and detergents, cleaning and polishing preparations (NACE 24.52). <strong>The</strong> latter<br />

two sub-sectors have several things in common with the core pharmaceutical industry, which justifies<br />

their joint consideration.<br />

Exhibit 2.4-1: <strong>Business</strong> activities covered by the pharmaceutical industry (NACE Rev. 1.1)<br />

NACE Rev. 1.1<br />

DE 24.4<br />

DE 24.5<br />

<strong>Business</strong> Activity<br />

Manufacture of pharmaceuticals, medicinal chemicals and botanical products<br />

Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and<br />

toilet preparations.<br />

In contrast to most other parts of the chemical sector, subsumed under NACE 24 (manufacture of<br />

chemicals, chemical products and man-made fibres), the outputs of the pharmaceutical industry are<br />

mostly produced for end-users and not for other firms of the chemical industry. In addition, most of<br />

these products can have an immediate impact on human health. <strong>The</strong>refore, the industry has to meet<br />

high safety standards and is subject to many regulatory measures in order to ensure the consumers’<br />

safety.<br />

Finally, companies active in the sub-sectors analysed by e-<strong>Business</strong> W@tch often use similar<br />

distribution channels such as pharmacies and drugstores. For the sector studies, therefore, the term<br />

“pharmaceutical industry”, is intended to include the whole sector as defined above.<br />

62<br />

NACE revised version 1.1 – final draft 2002. See glossary for explanation.<br />

95

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!